| mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.9 |
| mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.9 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.0081 |
0.9 |
| mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |